A new era in oxygen therapeutics? From perfluorocarbon systems to haemoglobin-based oxygen carriers

Nitin B. Charbe, Francisco Castillo, Murtaza M. Tambuwala, Parteek Prasher, Dinesh Kumar Chellappan, Aurora Carreño, Saurabh Satija, Sachin Kumar Singh, Monica Gulati, Kamal Dua, José Vicente González-aramundiz, Flavia C. Zacconi

Research output: Contribution to journalReview articlepeer-review

Abstract

Blood transfusion is the key to life in case of traumatic emergencies, surgeries and in several pathological conditions. An important goal of whole blood or red blood cell transfusion is the fast delivery of oxygen to vital organs and restoration of circulation volume. Whole blood or red blood cell transfusion has several limitations. Free haemoglobin not only loses its tetrameric configuration and extracts via the kidney leading to nephrotoxicity but also scavenges nitric oxide (NO), leading to vasoconstriction and hypertension. PFC based formulations transport oxygen in vivo, the contribution in terms of clinical outcome is challenging. The oxygen-carrying capacity is not the only criterion for the successful development of haemoglobin-based oxygen carriers (HBOCs). This review is a bird's eye view on the present state of the PFCs and HBOCs in which we analyzed the current modifications made or which are underway in development, their promises, and hurdles in clinical implementation.
Original languageEnglish
Article number100927
Pages (from-to)1-102
Number of pages102
JournalBlood Reviews
Early online date21 Jan 2022
DOIs
Publication statusE-pub ahead of print - 21 Jan 2022

Bibliographical note

Funding Information:
This study was supported by ANID/CONICYT FONDECYT Postdoctorado Folio 3210316 from F.C. and ANID/CONICYT FO NDECYT Postdoctorado Folio 3180250 from N.B.C., Chile. A.C. thanks COLCIENCIAS (Ministerio de Ciencia Tecnología e Innovación - Colombia) for the fellowship No. 567/2012 to carry out Doctoral studies. The authors would like to thank Prof. M. Von Houssen L. for the English revision of this manuscript and Rolando Rebolledo M.D. for the medical revision. The figures and graphical abstract from this article were created with BioRender.com.

Funding Information:
This study was supported by ANID/CONICYT FONDECYT Postdoctorado Folio 3210316 from F.C. and ANID/CONICYT FONDECYT Postdoctorado Folio 3180250 from N.B.C., Chile. A.C. thanks COLCIENCIAS (Ministerio de Ciencia Tecnolog?a e Innovaci?n - Colombia) for the fellowship No. 567/2012 to carry out Doctoral studies. The authors would like to thank Prof. M. Von Houssen L. for the English revision of this manuscript and Rolando Rebolledo M.D. for the medical revision. The figures and graphical abstract from this article were created with BioRender.com.

Publisher Copyright:
© 2022

Keywords

  • Blood transfusion
  • Perfluorocarbons (PFCs)
  • Haemoglobin-based oxygen carriers (HBCOs)
  • Nitric oxide scavenging
  • Vasoconstriction
  • Recombinant haemoglobin

Fingerprint

Dive into the research topics of 'A new era in oxygen therapeutics? From perfluorocarbon systems to haemoglobin-based oxygen carriers'. Together they form a unique fingerprint.

Cite this